STOCK TITAN

[144] SOPHiA GENETICS SA SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

JURGI CAMBLONG reported multiple 10b5-1 sales of Common stock executed through Morgan Stanley Smith Barney LLC as broker. The excerpt lists individual sales from 12/29/2025 through 03/16/2026 with per-trade share counts and proceeds.

Examples shown include sales of 95,488 shares on 01/09/2026 and 37,299 shares on 01/22/2026, executed under a 10b5-1 plan. The filing lists Restricted Stock Units and trade dates; cash-flow treatment is not stated in the provided excerpt.

Positive

  • None.

Negative

  • None.

Insights

Multiple planned sales under a 10b5-1 plan; routine disposition activity.

The excerpt documents sequential 10b5-1 sales by JURGI CAMBLONG through Morgan Stanley Smith Barney LLC with specific trade dates and share counts (for example, 95,488 shares on 01/09/2026). These are labeled as 10b5-1 sales, indicating pre-arranged trading instructions.

Impact depends on the holder's broader position and plan terms; subsequent filings or a Form 4 would show post-transaction holdings. Timing and proceeds recipient details are not included in the excerpt; further filings may provide the full position and cash‑flow specifics.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Sophia Genetics Sa

NASDAQ:SOPH

View SOPH Stock Overview

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

371.96M
67.30M
Health Information Services
Healthcare
Link
Switzerland
Rolle